Kyverna Therapeutics and ElevateBio Announce Clinical and Commercial Supply Agreement

Kyverna Therapeutics, Inc. and ElevateBio have entered into a Clinical and Commercial Supply Agreement, as announced in a joint press release on July 27, 2026. This new agreement supersedes a previous one and outlines ElevateBio's commitment to provide development and manufacturing services for the clinical and commercial supply of Kyverna's product. The initial term of the agreement is five years.